SCD and metabolic dysfunction-associated steatotic liver disease: Interestingly, elevated ratios of 16:1 n7/16:0 and 18:1 n9/18:0 were reported in NAFLD patients [21,26,30], which suggests an increase of SCD1 activity in NAFLD conditions [17,21,26].